Mazzeo S, Caramella D, Lencioni R, De Liperi A, Falaschi F, Miccoli P, Marcocci C, Iacconi P, Molea N, Bruno Bossio G
Istituto di Radiologia, Università degli Studi di Pisa.
Radiol Med. 1995 Dec;90(6):747-55.
The authors report their 3-year experience with the diagnosis of parathyroid lesions in primary hyperparathyroidism patients in a geographic area where the occurrence of endemic goiter is medium. Our study was aimed at prospectively assessing preoperative imaging results in these patients. The following imaging methods were used: high-definition and color-Doppler ultrasonography (US), double-tracer 201Thallium-99mTechnetium (T1/Tc) subtraction scintigraphy, Computed Tomography (CT), Magnetic Resonance Imaging (MRI) and US-guided fine-needle aspiration of the suspected parathyroid lesions. Preoperative US and scintigraphy were performed in 50 patients with primary hyperparathyroidism; in addition, color-Doppler US studies were performed in 33 patients for vascular characterization of the lesions. In 19 patients, the suspected lesions were punctured under US guidance to measure parathormone (PTHa) and thyroglobulin (TGa) levels in the aspirated material. CT and MRI were performed in 9 patients, to identify a possible ectopic parathyroid gland. Surgery demonstrated 48 solitary parathyroid lesions and one double parathyroid adenoma. In one patient no abnormal parathyroid gland was found. Overall sensitivity rates of US and scintigraphy were 85.7% and 61.2%, respectively. In multinodular goiter patients, the sensitivity rates of US and scintigraphy were 71.4% and 47.6%, respectively. At color-Doppler US the presence of parenchymal vascularization was specific of parathyroid nodules and the method helped differentiate parathyroid lesions from thyroid nodules in 14 multinodular goiter patients. Overall PTHa sensitivity was 72.2% and its specificity 100%. Overall TGa sensitivity was 100% and specificity 94.7%. CT and MRI allowed the detection of 8 ectopic parathyroid lesions. In conclusion, in our personal experience, US should be preferred to double-tracer T1/Tc subtraction scintigraphy in the early examination of primary hyperparathyroidism patients. When US detects a suspected parathyroid lesion, color-Doppler US and PTH and TG sampling can make useful diagnostic tools for reducing false-positive results, especially when thyroid disease is associated.
作者报告了他们在一个地方性甲状腺肿发病率中等的地理区域对原发性甲状旁腺功能亢进患者进行甲状旁腺病变诊断的3年经验。我们的研究旨在前瞻性评估这些患者的术前影像学检查结果。使用了以下影像学方法:高分辨率彩色多普勒超声(US)、双示踪剂201铊-99m锝(T1/Tc)减影闪烁扫描、计算机断层扫描(CT)、磁共振成像(MRI)以及US引导下对疑似甲状旁腺病变进行细针穿刺抽吸。对50例原发性甲状旁腺功能亢进患者进行了术前US和闪烁扫描;此外,对33例患者进行了彩色多普勒US检查,以对病变进行血管特征分析。在19例患者中,在US引导下对疑似病变进行穿刺,以测量抽吸物中的甲状旁腺激素(PTHa)和甲状腺球蛋白(TGa)水平。对9例患者进行了CT和MRI检查,以确定是否存在异位甲状旁腺。手术发现48个孤立性甲状旁腺病变和1个双发性甲状旁腺腺瘤。1例患者未发现异常甲状旁腺。US和闪烁扫描的总体敏感度分别为85.7%和61.2%。在多结节性甲状腺肿患者中,US和闪烁扫描的敏感度分别为71.4%和47.6%。在彩色多普勒US检查中,实质血管化的存在是甲状旁腺结节的特征,该方法有助于在14例多结节性甲状腺肿患者中将甲状旁腺病变与甲状腺结节区分开来。总体PTHa敏感度为72.2%,特异性为100%。总体TGa敏感度为100%,特异性为94.7%。CT和MRI检测到8个异位甲状旁腺病变。总之,根据我们的个人经验,在原发性甲状旁腺功能亢进患者的早期检查中,US应优于双示踪剂T1/Tc减影闪烁扫描。当US检测到疑似甲状旁腺病变时,彩色多普勒US以及PTH和TG采样可成为减少假阳性结果的有用诊断工具,尤其是在合并甲状腺疾病时。